15. Reed JC (1995) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541–546. 16. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl- 2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336. 17. Chao DT, Korsemeyer SJ (1998) Bcl-2 family: regulators of cell death. Ann Rev Immunol 16: 395–419. 18. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309–13012. 19. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312–1316. 20. Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049–20052. 21. Morgan DO (1995) Principles of CDK regulation. Nature (Lond) 374: 131–134. 22. Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and CIP and INK4 inhibitors. J Mol Biol 287: 821–828. 23. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73–87. 24. Fischer PM (2001) Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors. Curr Opin Drug Discov Devel 4: 623–634. 25. Ye X, Krohn RL, Liu W, Joshi SS, Kuszynski CA, et al. (1999) The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem 196: 99–108. 26. Mantena SK, Baliga MS, Katiyar SK (2006) Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 27: 1682–1691. 27. Bursch W, Oberhammer F, Schulte-Hermann R (1992) Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13: 245–251. 28. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539–542. Proanthocyanidins Inhibit Growth of Lung Cancer 29. Wright SC, Zhong J, Larrick JW (1994) Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J 8: 654–660. 30. Barry MA, Behnke CA, Eastmann A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharmacol 40: 2353–2362. 31. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121–129. 32. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 94: 2345–2349. 33. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637–640. 34. Donovan M, Cotter TG (2004) Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 1644: 133–147. 35. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC) 275: 1132–1136. 36. Grana X, Reddy P (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-depen- dent kinase inhibitors (CDKIs). Oncogene 11: 211–219. 37. Kastan MB, Canman CE, Leonard CJ (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3–15. 38. Molinari M (2000) Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33: 261–274. 39. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21. Cell 78: 67–74. 40. Hunter T, Pine J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573–582. 41. Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J 22: 659–661. PLoS ONE | www.plosone.org 13 November 2011 | Volume 6 | Issue 11 | e27444